{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:11:13Z","timestamp":1788883873837,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82500224"],"award-info":[{"award-number":["82500224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82502847"],"award-info":[{"award-number":["82502847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02165-2","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:53:43Z","timestamp":1788882823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brusatol Triggers Cell Cycle Arrest and Apoptosis, Disrupts Sterol Biosynthesis, and Enhances the Anti-Leukemic Activity of Venetoclax in AML Cells"],"prefix":"10.1007","author":[{"given":"Xuan","family":"chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"5","key":"2165_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"DA Pollyea","year":"2023","unstructured":"Pollyea, D. A., Altman, J. K., Assi, R., Bixby, D., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jonas, B. A., Kishtagari, A., et al. (2023). Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network, 21(5), 503\u2013513.","journal-title":"Journal Of The National Comprehensive Cancer Network"},{"key":"2165_CR2","doi-asserted-by":"publisher","first-page":"126078","DOI":"10.1016\/j.ijpharm.2025.126078","volume":"683","author":"Q Pan","year":"2025","unstructured":"Pan, Q., & Mahato, R. I. (2025). Recent advances in drug delivery and treatment strategies for acute myeloid leukemia. International Journal Of Pharmaceutics, 683, 126078.","journal-title":"International Journal Of Pharmaceutics"},{"issue":"1","key":"2165_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.2019000943","volume":"136","author":"AJ Dunbar","year":"2020","unstructured":"Dunbar, A. J., Rampal, R. K., & Levine, R. (2020). Leukemia secondary to myeloproliferative neoplasms. Blood, 136(1), 61\u201370.","journal-title":"Blood"},{"key":"2165_CR4","doi-asserted-by":"publisher","first-page":"107099","DOI":"10.1016\/j.phrs.2024.107099","volume":"202","author":"T Chen","year":"2024","unstructured":"Chen, T., Xiao, Z., Liu, X., Wang, T., Wang, Y., Ye, F., Su, J., Yao, X., Xiong, L., & Yang, D. H. (2024). Natural products for combating multidrug resistance in cancer. Pharmacological Research, 202, 107099.","journal-title":"Pharmacological Research"},{"key":"2165_CR5","doi-asserted-by":"publisher","first-page":"114134","DOI":"10.1016\/j.biopha.2022.114134","volume":"158","author":"T He","year":"2023","unstructured":"He, T., Zhou, F., Su, A., Zhang, Y., Xing, Z., Mi, L., Li, Z., & Wu, W. (2023). Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica. Biomedicine & Pharmacotherapy, 158, 114134.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2165_CR6","doi-asserted-by":"publisher","first-page":"157585","DOI":"10.1016\/j.phymed.2025.157585","volume":"150","author":"K Zhang","year":"2026","unstructured":"Zhang, K., Ni, X., Wang, C., Guo, J., Fan, W., Jiang, T., & Zhang, G. (2026). Brusatol inhibits gastric cancer by targeting P4HA2 and supressing glycolysis-driven histone lactylation. Phytomedicine, 150, 157585.","journal-title":"Phytomedicine"},{"key":"2165_CR7","doi-asserted-by":"publisher","first-page":"154567","DOI":"10.1016\/j.phymed.2022.154567","volume":"109","author":"QH Huang","year":"2023","unstructured":"Huang, Q. H., Zhang, J., Cho, W. C. S., Huang, Y., Yang, W., Zuo, Z., Xian, Y. F., & Lin, Z. X. (2023). Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K\/YAP1\/TAZ Pathway. Phytomedicine, 109, 154567.","journal-title":"Phytomedicine"},{"key":"2165_CR8","doi-asserted-by":"publisher","first-page":"157142","DOI":"10.1016\/j.phymed.2025.157142","volume":"146","author":"B Ma","year":"2025","unstructured":"Ma, B., Wang, L., Li, J., Zhang, B., Wang, Y., Li, N., Shen, D., & Han, C. (2025). Brusatol suppresses malignant progression of glioma via modulating the miR-574-5p\/USP10\/PLK1 axis. Phytomedicine, 146, 157142.","journal-title":"Phytomedicine"},{"issue":"9","key":"2165_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10092207","volume":"10","author":"J Jorge","year":"2022","unstructured":"Jorge, J., Magalhaes, N., Alves, R., Lapa, B., Goncalves, A. C., & Sarmento-Ribeiro, A. B. (2022). Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation. Biomedicines, 10(9), 1\u201314.","journal-title":"Biomedicines"},{"issue":"5","key":"2165_CR10","doi-asserted-by":"publisher","first-page":"e0177227","DOI":"10.1371\/journal.pone.0177227","volume":"12","author":"S Karathedath","year":"2017","unstructured":"Karathedath, S., Rajamani, B. M., Musheer Aalam, S. M., Abraham, A., Varatharajan, S., Krishnamurthy, P., Mathews, V., Velayudhan, S. R., & Balasubramanian, P. (2017). Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2. PLoS One, 12(5), e0177227.","journal-title":"PLoS One"},{"key":"2165_CR11","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.biopha.2021.111652","volume":"142","author":"C Cheng","year":"2021","unstructured":"Cheng, C., Yuan, F., Chen, X. P., Zhang, W., Zhao, X. L., Jiang, Z. P., Zhou, H. H., Zhou, G., & Cao, S. (2021). Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C. Biomedicine & Pharmacotherapy, 142, 111652.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6487","key":"2165_CR12","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020). Metabolic reprogramming and cancer progression. Science, 368(6487), eaaw5473.","journal-title":"Science"},{"issue":"1","key":"2165_CR13","doi-asserted-by":"publisher","first-page":"8860","DOI":"10.1038\/s41467-025-63912-2","volume":"16","author":"A Jouinot","year":"2025","unstructured":"Jouinot, A., Martin, Y., Violon, F., Foulonneau, T., Bendjelal, Y., Calvet, P., Izac, B., Letourneur, F., Bertholle, C., Andrieu, M., et al. (2025). Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors. Nature Communications, 16(1), 8860.","journal-title":"Nature Communications"},{"issue":"4","key":"2165_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/EBC20240028","volume":"68","author":"LI Beevors","year":"2024","unstructured":"Beevors, L. I., Sundar, S., & Foster, P. A. (2024). Steroid metabolism and hormonal dynamics in normal and malignant ovaries. Essays In Biochemistry, 68(4), 491\u2013507.","journal-title":"Essays In Biochemistry"},{"issue":"1","key":"2165_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12964-019-0505-5","volume":"18","author":"H Neuwirt","year":"2020","unstructured":"Neuwirt, H., Bouchal, J., Kharaishvili, G., Ploner, C., Johrer, K., Pitterl, F., Weber, A., Klocker, H., & Eder, I. E. (2020). Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis. Cell Commun Signal, 18(1), 11.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"2165_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41391-022-00590-x","volume":"26","author":"MJ Sakellakis","year":"2023","unstructured":"Sakellakis, M. J., Hahn, A. W., Ramachandran, S., Zhang, M., Hoang, A., Song, J. H., Liu, J., Wang, F., Basu, H. S., Sheperd, P., et al. (2023). Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate Cancer And Prostatic Diseases, 26(4), 751\u2013758.","journal-title":"Prostate Cancer And Prostatic Diseases"},{"issue":"1","key":"2165_CR17","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1038\/s41467-020-17339-6","volume":"11","author":"B Mahata","year":"2020","unstructured":"Mahata, B., Pramanik, J., van der Weyden, L., Polanski, K., Kar, G., Riedel, A., Chen, X., Fonseca, N. A., Kundu, K., Campos, L. S., et al. (2020). Tumors induce de novo steroid biosynthesis in T cells to evade immunity. Nature Communications, 11(1), 3588.","journal-title":"Nature Communications"},{"key":"2165_CR18","doi-asserted-by":"publisher","first-page":"115820","DOI":"10.1016\/j.biopha.2023.115820","volume":"168","author":"M Hu","year":"2023","unstructured":"Hu, M., Li, W., Zhang, Y., Liang, C., Tan, J., & Wang, Y. (2023). Venetoclax in adult acute myeloid leukemia. Biomedicine & Pharmacotherapy, 168, 115820.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"2165_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-021-00870-3","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Riley-Gillis, B., Han, L., Jia, Y., Lodi, A., Zhang, H., Ganesan, S., Pan, R., Konoplev, S. N., Sweeney, S. R., et al. (2022). Activation of RAS\/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther, 7(1), 51.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2165_CR20","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.pharmr.2024.100030","volume":"77","author":"A Glaviano","year":"2025","unstructured":"Glaviano, A., Singh, S. K., Lee, E. H. C., Okina, E., Lam, H. Y., Carbone, D., Reddy, E. P., O\u2019Connor, M. J., Koff, A., Singh, G., et al. (2025). Cell cycle dysregulation in cancer. Pharmacological Reviews, 77(2), 100030.","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"2165_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41375-022-01755-2","volume":"37","author":"VY Ling","year":"2023","unstructured":"Ling, V. Y., Straube, J., Godfrey, W., Haldar, R., Janardhanan, Y., Cooper, L., Bruedigam, C., Cooper, E., Tavakoli Shirazi, P., Jacquelin, S., et al. (2023). Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia. Leukemia, 37(1), 143\u2013153.","journal-title":"Leukemia"},{"issue":"1","key":"2165_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s10020-022-00555-9","volume":"28","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Cheng, Z., & Liu, S. (2022). MCM2 in human cancer: functions, mechanisms, and clinical significance. Molecular Medicine, 28(1), 128.","journal-title":"Molecular Medicine"},{"issue":"7882","key":"2165_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-021-03804-9","volume":"598","author":"J Green","year":"2021","unstructured":"Green, J., Hoehler, T., Neveu, M., Domagal-Goldman, S., Scalice, D., & Voytek, M. (2021). Call for a framework for reporting evidence for life beyond Earth. Nature, 598(7882), 575\u2013579.","journal-title":"Nature"},{"issue":"11","key":"2165_CR24","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.celrep.2015.11.018","volume":"13","author":"Y Quan","year":"2015","unstructured":"Quan, Y., Xia, Y., Liu, L., Cui, J., Li, Z., Cao, Q., Chen, X. S., Campbell, J. L., & Lou, H. (2015). Cell-Cycle-Regulated Interaction between Mcm10 and Double Hexameric Mcm2-7 Is Required for Helicase Splitting and Activation during S Phase. Cell Rep, 13(11), 2576\u20132586.","journal-title":"Cell Rep"},{"key":"2165_CR25","doi-asserted-by":"publisher","first-page":"25513","DOI":"10.1038\/srep25513","volume":"6","author":"V Alvarez","year":"2016","unstructured":"Alvarez, V., Vinas, L., Gallego-Sanchez, A., Andres, S., Sacristan, M. P., & Bueno, A. (2016). Orderly progression through S-phase requires dynamic ubiquitylation and deubiquitylation of PCNA. Scientific Reports, 6, 25513.","journal-title":"Scientific Reports"},{"issue":"4","key":"2165_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1535-6108(03)00084-9","volume":"3","author":"PW Hinds","year":"2003","unstructured":"Hinds, P. W. (2003). Cdk2 dethroned as master of S phase entry. Cancer Cell, 3(4), 305\u2013307.","journal-title":"Cancer Cell"},{"issue":"1","key":"2165_CR27","doi-asserted-by":"publisher","first-page":"2227489","DOI":"10.1080\/16078454.2023.2227489","volume":"28","author":"K Chen","year":"2023","unstructured":"Chen, K., Ning, X., Yan, X., & Song, L. (2023). Circ_0104700 contributes to acute myeloid leukemia progression by enhancing MCM2 expression through targeting miR-665. Hematology, 28(1), 2227489.","journal-title":"Hematology"},{"key":"2165_CR28","doi-asserted-by":"publisher","first-page":"35561","DOI":"10.1038\/srep35561","volume":"6","author":"D Ohayon","year":"2016","unstructured":"Ohayon, D., De Chiara, A., Chapuis, N., Candalh, C., Mocek, J., Ribeil, J. A., Haddaoui, L., Ifrah, N., Hermine, O., Bouillaud, F., et al. (2016). Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia. Scientific Reports, 6, 35561.","journal-title":"Scientific Reports"},{"issue":"4","key":"2165_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.leu.2402092","volume":"15","author":"N Radosevic","year":"2001","unstructured":"Radosevic, N., Delmer, A., Tang, R., Marie, J. P., & Ajchenbaum-Cymbalista, F. (2001). Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. Leukemia, 15(4), 559\u2013566.","journal-title":"Leukemia"},{"issue":"1","key":"2165_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","volume":"23","author":"X Peng","year":"2018","unstructured":"Peng, X., Chen, Z., Farshidfar, F., Xu, X., Lorenzi, P. L., Wang, Y., Cheng, F., Tan, L., Mojumdar, K., Du, D., et al. (2018). Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep, 23(1), 255\u2013269e254.","journal-title":"Cell Rep"},{"issue":"1","key":"2165_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1158\/1078-0432.CCR-13-0122","volume":"20","author":"L Gabitova","year":"2014","unstructured":"Gabitova, L., Gorin, A., & Astsaturov, I. (2014). Molecular pathways: sterols and receptor signaling in cancer. Clinical Cancer Research, 20(1), 28\u201334.","journal-title":"Clinical Cancer Research"},{"key":"2165_CR32","doi-asserted-by":"publisher","first-page":"216609","DOI":"10.1016\/j.canlet.2024.216609","volume":"584","author":"X Mei","year":"2024","unstructured":"Mei, X., Xiong, J., Liu, J., Huang, A., Zhu, D., Huang, Y., & Wang, H. (2024). DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4\/PI3K\/AKT axis and VEGF-C secretion. Cancer Letters, 584, 216609.","journal-title":"Cancer Letters"},{"key":"2165_CR33","doi-asserted-by":"publisher","first-page":"217901","DOI":"10.1016\/j.canlet.2025.217901","volume":"630","author":"X Wang","year":"2025","unstructured":"Wang, X., Li, Y., Tang, Y., Liu, Z., Liu, Y., Fu, X., Guo, S., Ma, J., Ma, F., Zhu, Z., et al. (2025). PD-L1 delactylation-promoted nuclear translocation accelerates liver cancer growth through elevating SQLE transcription activity. Cancer Letters, 630, 217901.","journal-title":"Cancer Letters"},{"issue":"1","key":"2165_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13287-024-04102-7","volume":"15","author":"H Mo","year":"2024","unstructured":"Mo, H., Shao, J., Li, Z., Zeng, P., Yin, X., Huang, Y., Wang, P., & Liao, J. (2024). FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway. Stem Cell Research & Therapy, 15(1), 492.","journal-title":"Stem Cell Research & Therapy"},{"issue":"4","key":"2165_CR35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bjh.70346","volume":"208","author":"X Dai","year":"2026","unstructured":"Dai, X., Wu, Z., Zhang, W., Chen, S., Zhao, X., Lu, Y., Ma, Y., & Zheng, W. (2026). DHCR7 drives AML development through the IL6\/JAK2\/STAT3 signalling pathway. British Journal Of Haematology, 208(4), 1263\u20131277.","journal-title":"British Journal Of Haematology"},{"issue":"1","key":"2165_CR36","first-page":"9","volume":"29","author":"YQ Ma","year":"2021","unstructured":"Ma, Y. Q., Liu, Y. C., Yin, C. L., Wang, L. L., Liu, D. H., Shi, J. L., & Dou, L. P. (2021). [Value of SQLE Expression in Prognostic Evaluation of Patients with Acute Myeloid Leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 29(1), 9\u201316.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2165_CR37","doi-asserted-by":"publisher","first-page":"150046","DOI":"10.1016\/j.bbrc.2024.150046","volume":"719","author":"N Li","year":"2024","unstructured":"Li, N., Wang, G., Guo, M., Zhu, N., & Yu, W. (2024). The mechanism and clinical application of farnesyl diphosphate farnesyltransferase 1 in cancer metabolism. Biochemical And Biophysical Research Communications, 719, 150046.","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"1","key":"2165_CR38","doi-asserted-by":"publisher","first-page":"2381171","DOI":"10.1080\/16078454.2024.2381171","volume":"29","author":"J Lian","year":"2024","unstructured":"Lian, J., Zhuang, H., Li, F., Pei, R., Chen, D., Ye, P., Li, S., Wang, T., Cao, J., Yuan, J., et al. (2024). High expression of EBP is an adverse prognostic factor for de novo acute myeloid leukemia. Hematology, 29(1), 2381171.","journal-title":"Hematology"},{"issue":"3","key":"2165_CR39","doi-asserted-by":"publisher","first-page":"e58833","DOI":"10.1371\/journal.pone.0058833","volume":"8","author":"P Singh","year":"2013","unstructured":"Singh, P., Saxena, R., Srinivas, G., Pande, G., & Chattopadhyay, A. (2013). Cholesterol biosynthesis and homeostasis in regulation of the cell cycle. PLoS One, 8(3), e58833.","journal-title":"PLoS One"},{"key":"2165_CR40","doi-asserted-by":"publisher","first-page":"114623","DOI":"10.1016\/j.bcp.2021.114623","volume":"196","author":"MA Lasuncion","year":"2022","unstructured":"Lasuncion, M. A., Martinez-Botas, J., Martin-Sanchez, C., Busto, R., & Gomez-Coronado, D. (2022). Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids. Biochemical Pharmacology, 196, 114623.","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"2165_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbalip.2005.02.003","volume":"1734","author":"Y Suarez","year":"2005","unstructured":"Suarez, Y., Fernandez, C., Ledo, B., Martin, M., Gomez-Coronado, D., & Lasuncion, M. A. (2005). Sterol stringency of proliferation and cell cycle progression in human cells. Biochimica Et Biophysica Acta, 1734(2), 203\u2013213.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"2","key":"2165_CR42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.20517\/cdr.2021.125","volume":"5","author":"F Ong","year":"2022","unstructured":"Ong, F., Kim, K., & Konopleva, M. Y. (2022). Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist, 5(2), 380\u2013400.","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"2165_CR43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei, S., Pollyea, D. A., Gustafson, A., Stevens, B. M., Minhajuddin, M., Fu, R., Riemondy, K. A., Gillen, A. E., Sheridan, R. M., Kim, J., et al. (2020). Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia. Cancer Discovery, 10(4), 536\u2013551.","journal-title":"Cancer Discovery"},{"issue":"1","key":"2165_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X., Wang, Y., Tan, J., Li, Y., Yang, P., Liu, X., Lai, J., Zhang, Y., Cai, L., Gu, Y., et al. (2024). Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov, 10(1), 35.","journal-title":"Cell Death Discov"},{"issue":"3","key":"2165_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/antiox11030461","volume":"11","author":"HA Alkhatabi","year":"2022","unstructured":"Alkhatabi, H. A., Zohny, S. F., Shait Mohammed, M. R., Choudhry, H., Rehan, M., Ahmad, A., Ahmed, F., & Khan, M. I. (2022). Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K\/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for Survival. Antioxidants (Basel), 11(3), 461.","journal-title":"Antioxidants (Basel)"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02165-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:53:44Z","timestamp":1788882824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02165-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":45,"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02165-2","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"19 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}